Evidence map›Paper›PMID 41334497›Full record

ArticleJSLS : Journal of the Society of Laparoendoscopic Surgeons

Outcomes of Bilateral Inguinal Hernia Repair: A Dual-Mesh Laparoscopic TEP Technique.

Sergio Susmallian, Oleg Ponomarenko, Ilan Charuzi

Abstract read
In one paragraph

Article in JSLS : Journal of the Society of Laparoendoscopic Surgeons. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sergio SusmallianAssuta Medical Center, Tel Aviv, Israel. (Dr. Susmallian).
Oleg PonomarenkoDepartment of General and Thoracic Surgery, Barzilai Medical Center, Ashkelon, Israel. (Dr. Ponomarenko).
Ilan CharuziIndependent researcher. (Dr. Charuzi).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study evaluates the long-term safety, efficacy, and recurrence of laparoscopic totally extraperitoneal (TEP) repair for bilateral inguinal hernias using a dual-mesh technique. Background: TEP repair is a well-established approach for inguinal hernia, offering advantages such as reduced postoperative pain, faster recovery, and fewer wound complications. Methods: A retrospective review was conducted of 426 patients with bilateral inguinal hernias who underwent TEP repair between January 2012 and May 2025. All procedures were performed by a single experienced surgeon using the standardized dual-mesh technique. Results: The mean patient age was 48.46 years (range: 17-82). The mean operative time was 47.73 minutes, and the hospital stay was 27.45 hours. The mean follow-up was 74.2 months (range: 12-188). The overall complication rate was low: 34 (7.9%) cases of seroma, urinary retention 2 (0.47%), hematoma 6 (1.4%), hydrocele 3 (0.7%), and no mesh-related infections or chronic pain. Four recurrences (0.94%) were detected, attributed mainly to incomplete dissection, overlooked cord lipomas, or mesh shrinkage. No complications were attributable to the overlapping dual-mesh technique. No intensive care admissions, or deaths occurred. Conclusion: Laparoscopic TEP repair with the novel dual-mesh technique provides reliable reinforcement of the myopectineal orifice (MPO), yielding low recurrence rates while avoiding vascular injury or mesh-related complications.

Indexed as

Hernia, InguinalHerniorrhaphyLaparoscopySurgical MeshAdolescentAdultAgedAged, 80 and overFemaleHumansLength of StayMaleMiddle AgedOperative TimePostoperative ComplicationsRecurrenceComplicationsInguinal herniaLaparoscopyMeshRecurrence

Identifiers

PMID41334497
PMCPMC12668379

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.